Dr. Qureshi will act as President of the Foundation for a year-long term
CRANFORD, N.J.–(BUSINESS WIRE)–Dr. M. Nasar Qureshi, President and Chief Medical Officer of QDx Pathology Services, a national, independent and full-service anatomical and molecular pathology laboratory, has been named President of the American Pakistan Foundation (APF). APF is an organization dedicated to empowering the Pakistani American community and building bridges between the U.S. and Pakistan.
Qureshi joined the Board of the American Pakistan Foundation in 2018. After serving on the executive committee, he was selected as Chairman of the Board in October of 2020. Dr. Qureshi was chosen for the role due to his lifelong service to the community, dedication to his work and entrepreneurial spirit. APF serves its mission with leaders like Dr. Qureshi, who recognize the potential of young Pakistani-American women and men to thrive in all aspects of American life.
“It has been an honor to help APF expand its offering of mentorship programs the past several years,” said Dr. Qureshi. “I look forward to spearheading the country’s first national network of Pakistani-American professionals and doing my best to ensure the next generation of Pakistani-Americans lead productive and successful lives in this country.”
Dr. Qureshi, M.D., Ph.D., is a recognized leader in the medical field for diagnostic excellence. He completed professional training at Tulane University School of Medicine, Mount Sinai Hospital, Beth Israel Medical Center and North Shore University Hospital. Dr. Qureshi specializes in clinical and anatomical pathology and has contributed to more than 50 articles published in peer-reviewed journals. He has also served as the lead investigator for several institutional and NIH-funded grants.
While in medical training, Dr. Qureshi continued his passion for community involvement and social work by joining the Association of Physicians of Pakistani Descent of North America (APPNA) and serving as the President of the New Jersey Chapter of APPNA and the Dow Medical Alumni Association. After serving in various roles for APPNA, he was selected as President of the organization for 2016.
In his professional life, Dr. Qureshi established a free-standing reference laboratory, QDx Pathology Services, in 2006 in New Jersey, as a center of excellence in surgical pathology. QDx Pathology has grown to command referrals from physicians nationwide, especially in the fields of gastrointestinal, urologic and gynecologic pathology. Dr. Qureshi serves as the President and Chief Medical Officer of QDx Pathology.
About the American Pakistan Foundation
Through cultural and intellectual exchanges; the promotion of domestic and foreign policy literacy; and mentorship of the next generation, APF empowers the Pakistani American community in all aspects of American life. In doing so, it shapes the diverse and multifaceted story of the United States, made possible by a vibrant and successful Pakistani American community that prioritizes charity, giving back to the United States, and investing in its homeland of Pakistan. Under Dr. Qureshi’s leadership, the American Pakistan Foundation will continue to thrive and excel in its impact and reach to all communities that share its values.
About QDx Pathology Services
QDx Pathology Services is a privately held, CLIA-certified facility located in Central New Jersey, serving medical professionals throughout the country. Its mission is to deliver diagnostic excellence and accuracy for every patient utilizing the latest, state-of-the-art instrumentation and medical technology. QDx offers direct access to highly experienced, board-certified pathology staff with an average of 15 years of experience.
Contacts
MEDIA CONTACT:
Erin Horne
erin@reedpublicrelations.com
847-421-6204
MEMPHIS, Tenn., July 5, 2024 /PRNewswire/ -- Methodist Le Bonheur Healthcare announced its four Memphis-based adult hospitals…
TEMPE, Ariz., July 5, 2024 /PRNewswire/ -- Economic activity in the hospital subsector grew in June…
mCare Digital unveils the mCareWatch MW-241 powered by KORE connectivity ATLANTA, July 5, 2024 /PRNewswire/…
Shareholders approved a dividend distribution of € 2.00 per ordinary share; representing an increase of…
Image acquisition and defocusing correction techniques enable observations of atomic-scale magnetic fields at never-before-seen resolution…
Marlborough, Massachusetts--(Newsfile Corp. - July 5, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical…